HEADER STRUCTURAL PROTEIN 23-NOV-21 7W29 TITLE CRYSTAL STRUCTURE OF SETD3-SAH IN COMPLEX WITH BETAA-ORN73 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIN, CYTOPLASMIC 1, N-TERMINALLY PROCESSED; COMPND 3 CHAIN: P; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE SETD3; COMPND 7 CHAIN: A; COMPND 8 FRAGMENT: SETD3; COMPND 9 SYNONYM: SET DOMAIN-CONTAINING PROTEIN 3; COMPND 10 EC: 2.1.1.43; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: SETD3; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PSUMOH10 KEYWDS SET DOMAIN, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,H.MA REVDAT 2 29-NOV-23 7W29 1 REMARK REVDAT 1 05-OCT-22 7W29 0 JRNL AUTH J.C.J.HINTZEN,H.MA,H.DENG,A.WITECKA,S.B.ANDERSEN,J.DROZAK, JRNL AUTH 2 H.GUO,P.QIAN,H.LI,J.MECINOVIC JRNL TITL HISTIDINE METHYLTRANSFERASE SETD3 METHYLATES STRUCTURALLY JRNL TITL 2 DIVERSE HISTIDINE MIMICS IN ACTIN. JRNL REF PROTEIN SCI. V. 31 E4305 2022 JRNL REFN ESSN 1469-896X JRNL PMID 35481649 JRNL DOI 10.1002/PRO.4305 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 11636 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7100 - 5.7900 0.91 1348 151 0.2267 0.2556 REMARK 3 2 5.7900 - 4.5900 0.90 1250 159 0.2334 0.2754 REMARK 3 3 4.5900 - 4.0100 0.89 1225 136 0.2218 0.2569 REMARK 3 4 4.0100 - 3.6500 0.94 1279 146 0.2325 0.2797 REMARK 3 5 3.6500 - 3.3900 0.98 1347 139 0.2327 0.3013 REMARK 3 6 3.3900 - 3.1900 1.00 1353 149 0.2530 0.3099 REMARK 3 7 3.1900 - 3.0300 1.00 1363 134 0.2662 0.2738 REMARK 3 8 3.0300 - 2.9000 0.97 1318 139 0.2706 0.3403 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.750 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7W29 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1300025865. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11695 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.23900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.55200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 6MBJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%(W/V) PEG6000, 0.1M BICINE/SODIUM REMARK 280 HYDROXIDE 9.0, PH 9.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.23350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.02700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.83400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.02700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.23350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.83400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: P, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -1 REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 LYS A 2 REMARK 465 LYS A 3 REMARK 465 SER A 4 REMARK 465 ARG A 5 REMARK 465 VAL A 6 REMARK 465 LYS A 7 REMARK 465 THR A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 THR A 13 REMARK 465 GLY A 14 REMARK 465 ALA A 15 REMARK 465 THR A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 VAL A 19 REMARK 465 LYS A 495 REMARK 465 ALA A 496 REMARK 465 PRO A 497 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 103 -5.57 -140.97 REMARK 500 THR A 314 48.57 -81.97 REMARK 500 REMARK 500 REMARK: NULL DBREF 7W29 P 66 81 UNP P60709 ACTB_HUMAN 66 81 DBREF 7W29 A 0 497 UNP Q86TU7 SETD3_HUMAN 1 498 SEQADV 7W29 ORN P 73 UNP P60709 HIS 73 CONFLICT SEQADV 7W29 SER A -1 UNP Q86TU7 EXPRESSION TAG SEQRES 1 P 16 THR LEU LYS TYR PRO ILE GLU ORN GLY ILE VAL THR ASN SEQRES 2 P 16 TRP ASP ASP SEQRES 1 A 499 SER MET GLY LYS LYS SER ARG VAL LYS THR GLN LYS SER SEQRES 2 A 499 GLY THR GLY ALA THR ALA THR VAL SER PRO LYS GLU ILE SEQRES 3 A 499 LEU ASN LEU THR SER GLU LEU LEU GLN LYS CYS SER SER SEQRES 4 A 499 PRO ALA PRO GLY PRO GLY LYS GLU TRP GLU GLU TYR VAL SEQRES 5 A 499 GLN ILE ARG THR LEU VAL GLU LYS ILE ARG LYS LYS GLN SEQRES 6 A 499 LYS GLY LEU SER VAL THR PHE ASP GLY LYS ARG GLU ASP SEQRES 7 A 499 TYR PHE PRO ASP LEU MET LYS TRP ALA SER GLU ASN GLY SEQRES 8 A 499 ALA SER VAL GLU GLY PHE GLU MET VAL ASN PHE LYS GLU SEQRES 9 A 499 GLU GLY PHE GLY LEU ARG ALA THR ARG ASP ILE LYS ALA SEQRES 10 A 499 GLU GLU LEU PHE LEU TRP VAL PRO ARG LYS LEU LEU MET SEQRES 11 A 499 THR VAL GLU SER ALA LYS ASN SER VAL LEU GLY PRO LEU SEQRES 12 A 499 TYR SER GLN ASP ARG ILE LEU GLN ALA MET GLY ASN ILE SEQRES 13 A 499 ALA LEU ALA PHE HIS LEU LEU CYS GLU ARG ALA SER PRO SEQRES 14 A 499 ASN SER PHE TRP GLN PRO TYR ILE GLN THR LEU PRO SER SEQRES 15 A 499 GLU TYR ASP THR PRO LEU TYR PHE GLU GLU ASP GLU VAL SEQRES 16 A 499 ARG TYR LEU GLN SER THR GLN ALA ILE HIS ASP VAL PHE SEQRES 17 A 499 SER GLN TYR LYS ASN THR ALA ARG GLN TYR ALA TYR PHE SEQRES 18 A 499 TYR LYS VAL ILE GLN THR HIS PRO HIS ALA ASN LYS LEU SEQRES 19 A 499 PRO LEU LYS ASP SER PHE THR TYR GLU ASP TYR ARG TRP SEQRES 20 A 499 ALA VAL SER SER VAL MET THR ARG GLN ASN GLN ILE PRO SEQRES 21 A 499 THR GLU ASP GLY SER ARG VAL THR LEU ALA LEU ILE PRO SEQRES 22 A 499 LEU TRP ASP MET CYS ASN HIS THR ASN GLY LEU ILE THR SEQRES 23 A 499 THR GLY TYR ASN LEU GLU ASP ASP ARG CYS GLU CYS VAL SEQRES 24 A 499 ALA LEU GLN ASP PHE ARG ALA GLY GLU GLN ILE TYR ILE SEQRES 25 A 499 PHE TYR GLY THR ARG SER ASN ALA GLU PHE VAL ILE HIS SEQRES 26 A 499 SER GLY PHE PHE PHE ASP ASN ASN SER HIS ASP ARG VAL SEQRES 27 A 499 LYS ILE LYS LEU GLY VAL SER LYS SER ASP ARG LEU TYR SEQRES 28 A 499 ALA MET LYS ALA GLU VAL LEU ALA ARG ALA GLY ILE PRO SEQRES 29 A 499 THR SER SER VAL PHE ALA LEU HIS PHE THR GLU PRO PRO SEQRES 30 A 499 ILE SER ALA GLN LEU LEU ALA PHE LEU ARG VAL PHE CYS SEQRES 31 A 499 MET THR GLU GLU GLU LEU LYS GLU HIS LEU LEU GLY ASP SEQRES 32 A 499 SER ALA ILE ASP ARG ILE PHE THR LEU GLY ASN SER GLU SEQRES 33 A 499 PHE PRO VAL SER TRP ASP ASN GLU VAL LYS LEU TRP THR SEQRES 34 A 499 PHE LEU GLU ASP ARG ALA SER LEU LEU LEU LYS THR TYR SEQRES 35 A 499 LYS THR THR ILE GLU GLU ASP LYS SER VAL LEU LYS ASN SEQRES 36 A 499 HIS ASP LEU SER VAL ARG ALA LYS MET ALA ILE LYS LEU SEQRES 37 A 499 ARG LEU GLY GLU LYS GLU ILE LEU GLU LYS ALA VAL LYS SEQRES 38 A 499 SER ALA ALA VAL ASN ARG GLU TYR TYR ARG GLN GLN MET SEQRES 39 A 499 GLU GLU LYS ALA PRO HET ORN P 73 8 HET SAH A 501 26 HETNAM ORN L-ORNITHINE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE FORMUL 1 ORN C5 H12 N2 O2 FORMUL 3 SAH C14 H20 N6 O5 S FORMUL 4 HOH *38(H2 O) HELIX 1 AA1 PRO A 21 SER A 36 1 16 HELIX 2 AA2 LYS A 44 LYS A 62 1 19 HELIX 3 AA3 LYS A 73 ASP A 76 5 4 HELIX 4 AA4 TYR A 77 GLU A 87 1 11 HELIX 5 AA5 LYS A 125 LEU A 127 5 3 HELIX 6 AA6 VAL A 130 ASN A 135 1 6 HELIX 7 AA7 LEU A 138 ASP A 145 1 8 HELIX 8 AA8 ASP A 145 MET A 151 1 7 HELIX 9 AA9 MET A 151 ALA A 165 1 15 HELIX 10 AB1 TRP A 171 GLN A 176 1 6 HELIX 11 AB2 THR A 184 PHE A 188 5 5 HELIX 12 AB3 GLU A 189 TYR A 195 1 7 HELIX 13 AB4 GLN A 200 HIS A 226 1 27 HELIX 14 AB5 PRO A 227 ASN A 230 5 4 HELIX 15 AB6 THR A 239 ARG A 253 1 15 HELIX 16 AB7 LEU A 272 CYS A 276 5 5 HELIX 17 AB8 SER A 316 SER A 324 1 9 HELIX 18 AB9 LEU A 348 ALA A 359 1 12 HELIX 19 AC1 SER A 377 CYS A 388 1 12 HELIX 20 AC2 THR A 390 LEU A 399 1 10 HELIX 21 AC3 SER A 402 THR A 409 1 8 HELIX 22 AC4 SER A 418 THR A 439 1 22 HELIX 23 AC5 THR A 443 HIS A 454 1 12 HELIX 24 AC6 SER A 457 GLU A 494 1 38 SHEET 1 AA1 2 PHE A 95 PHE A 100 0 SHEET 2 AA1 2 GLY A 104 ALA A 109 -1 O GLY A 106 N VAL A 98 SHEET 1 AA2 3 LEU A 118 PRO A 123 0 SHEET 2 AA2 3 ARG A 293 VAL A 297 -1 O CYS A 296 N LEU A 120 SHEET 3 AA2 3 THR A 285 ASN A 288 -1 N ASN A 288 O ARG A 293 SHEET 1 AA3 3 MET A 128 THR A 129 0 SHEET 2 AA3 3 VAL A 265 LEU A 269 -1 O LEU A 269 N MET A 128 SHEET 3 AA3 3 GLN A 254 PRO A 258 -1 N ILE A 257 O THR A 266 SHEET 1 AA4 2 ASN A 277 HIS A 278 0 SHEET 2 AA4 2 TYR A 309 ILE A 310 1 O ILE A 310 N ASN A 277 SHEET 1 AA5 2 ARG A 335 GLY A 341 0 SHEET 2 AA5 2 SER A 364 HIS A 370 -1 O PHE A 367 N ILE A 338 LINK C GLU P 72 N ORN P 73 1555 1555 1.33 LINK C ORN P 73 N GLY P 74 1555 1555 1.33 CISPEP 1 GLU A 373 PRO A 374 0 -4.17 CRYST1 60.467 77.668 112.054 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016538 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012875 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008924 0.00000